speb/financial-data huggingface dataset:
CRESY income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 24678000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 3415000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -132000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Net PPE: 1103358000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -21744000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 29878000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1071158000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 202394000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Non Current Accrued Expenses: 466000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 16609000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1013025000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 16609000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1013025000000.00
CRESY income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 154302000000.00
CRESY income_statement (quarterly, 2025-12-31) — Normalized Income: 69765204157.19
CRESY cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -53633000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 27387000000.00
CRESY income_statement (quarterly, 2025-12-31) — Operating Income: 70731000000.00
CRESY income_statement (quarterly, 2025-12-31) — Operating Revenue: 307501000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 647000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: -2933000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 533492000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 3693000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 305249000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 341988000000.00
CRESY income_statement (quarterly, 2025-12-31) — Other Gand A: 33070000000.00
CRESY income_statement (quarterly, 2025-12-31) — Other Income Expense: -19781000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 24842000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Other Inventories: 187748000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -47098000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 56645000000.00
CRESY income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -9668000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Other Properties: 141831000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 285319000000.00
CRESY income_statement (quarterly, 2025-12-31) — Other Special Charges: -14559000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Payables: 489234000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 519541000000.00
CRESY income_statement (quarterly, 2025-12-31) — Pretax Income: 75628000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 10407000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CRESY cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 810000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -1003000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -513000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -462321000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Purchase Of Investment Properties: -28599000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -23131000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Raw Materials: 80845000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Receivables: 461458000000.00
CRESY income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 188212000000.00
CRESY income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5426000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -156627000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -24000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 58091000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CRESY cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 502727000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Sale Of Investment Properties: 1490000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 1387000000.00
CRESY income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 25156000000.00
CRESY income_statement (quarterly, 2025-12-31) — Selling General And Administration: 58226000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Share Issued: 648742437.00
CRESY income_statement (quarterly, 2025-12-31) — Special Income Charges: 14559000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1103635000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1071158000000.00
CRESY income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -225795842.81
CRESY income_statement (quarterly, 2025-12-31) — Tax Provision: 484000000.00
CRESY income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.01
CRESY balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 546000000.00
CRESY cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -60095000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Total Assets: 6319229000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2449232000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Total Debt: 2047246000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2606935000000.00
CRESY income_statement (quarterly, 2025-12-31) — Total Expenses: 236770000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3712294000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4732610000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2599843000000.00
CRESY income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 20890000000.00
CRESY income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -60559000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 54868000000.00
CRESY income_statement (quarterly, 2025-12-31) — Total Unusual Items: -35282000000.00
CRESY income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -35282000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 70713000000.00
CRESY balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 1742437.00
CRESY balance_sheet (quarterly, 2025-12-31) — Working Capital: 474168000000.00
CRESY income_statement (quarterly, 2026-03-31) — +Operating Expense: 72132000000.00
CRESY income_statement (quarterly, 2026-03-31) — +Total Revenue: 252687000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 425898000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 519771000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -375855000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 467002000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 3729000000.00
CRESY income_statement (quarterly, 2026-03-31) — Basic Average Shares: 64034417.00
CRESY income_statement (quarterly, 2026-03-31) — Basic EPS: 627.60
CRESY cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 434767000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 237556000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4046000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 168060000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Capital Stock: 707000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 139923000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 657021000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -9738000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 75525000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -237769000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -52743000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Change In Inventory: -128221000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -25810000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 13310000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Change In Payable: -59221000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -66179000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -138856000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Changes In Cash: -318511000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Common Stock: 707000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1307042000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 24000000.00
CRESY income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 134704000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 40574000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Current Assets: 1621000000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 57557000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Current Debt: 488374000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 545931000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1131838000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Current Provisions: 5865000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 4027000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Deferred Tax: 4027000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 6603000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 6603000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 4923000000.00
CRESY income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 64034417.00
CRESY income_statement (quarterly, 2026-03-31) — Diluted EPS: 627.60
CRESY income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 40188000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 2195000000.00
CRESY income_statement (quarterly, 2026-03-31) — EBIT: 60318000000.00
CRESY income_statement (quarterly, 2026-03-31) — EBITDA: 66921000000.00
CRESY income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 9301000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -679000000.00
CRESY cash_flow (quarterly, 2026-03-31) — End Cash Position: 139923000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Financial Assets: 2303000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -27999000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Finished Goods: 149434000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -56789000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 148244000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -20761000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -4000000.00
CRESY income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 782000000.00
CRESY income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -170699000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 379842000000.00
CRESY income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 35293000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Goodwill: 8293000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 35016000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1434945000000.00
CRESY income_statement (quarterly, 2026-03-31) — Gross Profit: 117983000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 15748000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 95725000000.00
CRESY income_statement (quarterly, 2026-03-31) — Interest Expense: 45490000000.00
CRESY income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 45490000000.00
CRESY income_statement (quarterly, 2026-03-31) — Interest Income: 4845000000.00
CRESY income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 4845000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -49921000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: -53238000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Inventory: 427460000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3082748000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -247769000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Investment Properties: 3264284000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 29546000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 280697000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 258095000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 959553000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 110503000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1287332000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1397835000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 258095000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -210860000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 251151000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 42190000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 83678000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1507749000000.00
CRESY income_statement (quarterly, 2026-03-31) — Minority Interests: 21122000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -721000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 24000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Net Debt: 1635783000000.00
CRESY income_statement (quarterly, 2026-03-31) — Net Income: 40188000000.00
CRESY income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 40188000000.00
CRESY income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 19066000000.00
CRESY income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 40188000000.00
CRESY income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 40188000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 37376000000.00
CRESY income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 19066000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -834000000.00
CRESY income_statement (quarterly, 2026-03-31) — Net Interest Income: 129593000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: -18642000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -176708000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 14880000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 47235000000.00
CRESY income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 129593000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -106024000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -9515000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Net PPE: 1059090000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 9694000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -32355000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1272026000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 158937000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 807000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 18458000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1045957000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 18458000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1045957000000.00
CRESY income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 236838000000.00
CRESY income_statement (quarterly, 2026-03-31) — Normalized Income: 142138200000.00
CRESY cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -52743000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 127479000000.00
CRESY income_statement (quarterly, 2026-03-31) — Operating Income: 45851000000.00
CRESY income_statement (quarterly, 2026-03-31) — Operating Revenue: 252687000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 709251964.00
CRESY cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: -2727000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 488374000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 17845000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 379842000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 355727000000.00
CRESY income_statement (quarterly, 2026-03-31) — Other Gand A: 35293000000.00
CRESY income_statement (quarterly, 2026-03-31) — Other Income Expense: -160616000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 26723000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Other Inventories: 225219000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -80236000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 67711000000.00
CRESY income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 14768000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Other Properties: 154158000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 517098000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Payables: 521623000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 562197000000.00
CRESY income_statement (quarterly, 2026-03-31) — Pretax Income: 14828000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 19256000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CRESY cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 15591000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -721000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -834000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -684173000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -19001000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -3212000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Raw Materials: 52807000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Receivables: 520771000000.00
CRESY income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 134704000000.00
CRESY income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 6603000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -210860000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 24000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 103764000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Sale Of Business: 0.00
CRESY cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 507465000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Sale Of Investment Properties: 359000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 12906000000.00
CRESY income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 22071000000.00
CRESY income_statement (quarterly, 2026-03-31) — Selling General And Administration: 57364000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Share Issued: 709308309.00
CRESY income_statement (quarterly, 2026-03-31) — Special Income Charges: 782000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1307042000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1272026000000.00
CRESY income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -67966800000.00
CRESY income_statement (quarterly, 2026-03-31) — Tax Provision: -4238000000.00
CRESY income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CRESY balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1000000000.00
CRESY cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -28456000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Total Assets: 6507496000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2594374000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Total Debt: 1943766000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2814791000000.00
CRESY income_statement (quarterly, 2026-03-31) — Total Expenses: 206836000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3692705000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 4886496000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2560867000000.00
CRESY income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -124066000000.00
CRESY income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -170238000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 95725000000.00
CRESY income_statement (quarterly, 2026-03-31) — Total Unusual Items: -169917000000.00
CRESY income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -169917000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 69155000000.00
CRESY balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 56345.00
CRESY balance_sheet (quarterly, 2026-03-31) — Working Capital: 489162000000.00
CREX income_statement (annual, 2021-12-31) — Basic Average Shares: 3920392.00
CREX income_statement (annual, 2021-12-31) — Basic EPS: 0.06
CREX balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 654000.00
CREX cash_flow (annual, 2021-12-31) — Change In Other Current Assets: 277000.00
CREX cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: -240000.00
CREX cash_flow (annual, 2021-12-31) — Common Stock Issuance: 1849000.00
CREX income_statement (annual, 2021-12-31) — Depreciation Amortization Depletion Income Statement: 1364000.00
CREX income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 1364000.00
CREX income_statement (annual, 2021-12-31) — Diluted Average Shares: 3920392.00
CREX income_statement (annual, 2021-12-31) — Diluted EPS: 0.06
CREX income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
CREX income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
CREX cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 1849000.00
CREX cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
CREX balance_sheet (annual, 2021-12-31) — Non Current Accrued Expenses: 0.00
CREX cash_flow (annual, 2021-12-31) — Operating Gains Losses: -3875000.00
CREX balance_sheet (annual, 2021-12-31) — Other Current Assets: 1634000.00
CREX balance_sheet (annual, 2021-12-31) — Other Inventories: 3000.00
CREX balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 45000.00
CREX income_statement (annual, 2021-12-31) — Other Operating Expenses: 518000.00
CREX balance_sheet (annual, 2021-12-31) — Other Receivables: 369000.00
CREX income_statement (annual, 2021-12-31) — Other Special Charges: -3449000.00
CREX cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: -785000.00
CREX balance_sheet (annual, 2021-12-31) — Prepaid Assets: 1634000.00
CREX cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 0.00
CREX income_statement (annual, 2021-12-31) — Research And Development: 550000.00
CREX cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
CREX cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -100000.00
CREX income_statement (annual, 2021-12-31) — Write Off: -277000.00
CREX income_statement (annual, 2022-12-31) — +Operating Expense: 19627000.00
CREX income_statement (annual, 2022-12-31) — +Total Revenue: 43350000.00
CREX balance_sheet (annual, 2022-12-31) — Accounts Payable: 3757000.00
CREX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 8263000.00
CREX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -457000.00
CREX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 75916000.00
CREX balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -984000.00
CREX cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 398000.00
CREX income_statement (annual, 2022-12-31) — Basic Average Shares: 6664666.00
CREX income_statement (annual, 2022-12-31) — Basic EPS: 0.28
CREX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2883000.00
CREX cash_flow (annual, 2022-12-31) — Capital Expenditure: -4289000.00
CREX cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -4140000.00
CREX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1584000.00
CREX balance_sheet (annual, 2022-12-31) — Capital Stock: 72000.00
CREX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1633000.00
CREX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1633000.00
CREX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 20933000.00
CREX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -21475000.00
CREX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -708000.00
CREX cash_flow (annual, 2022-12-31) — Change In Account Payable: 914000.00
CREX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 1112000.00
CREX cash_flow (annual, 2022-12-31) — Change In Inventory: -197000.00
CREX cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -399000.00
CREX cash_flow (annual, 2022-12-31) — Change In Payable: 914000.00
CREX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 2026000.00
CREX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 480000.00
CREX cash_flow (annual, 2022-12-31) — Change In Receivables: -3927000.00
CREX cash_flow (annual, 2022-12-31) — Change In Working Capital: -2017000.00
CREX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -3927000.00
CREX cash_flow (annual, 2022-12-31) — Changes In Cash: -1250000.00
CREX balance_sheet (annual, 2022-12-31) — Common Stock: 72000.00
CREX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 25579000.00
CREX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1814000.00
CREX income_statement (annual, 2022-12-31) — Cost Of Revenue: 25611000.00
CREX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 3828000.00
CREX balance_sheet (annual, 2022-12-31) — Current Assets: 13982000.00
CREX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 711000.00
CREX balance_sheet (annual, 2022-12-31) — Current Debt: 4499000.00
CREX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5210000.00
CREX balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 3701000.00
CREX balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 3701000.00
CREX balance_sheet (annual, 2022-12-31) — Current Liabilities: 16496000.00
CREX cash_flow (annual, 2022-12-31) — Deferred Income Tax: 0.00
CREX cash_flow (annual, 2022-12-31) — Deferred Tax: 0.00
CREX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2833000.00
CREX income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 2833000.00
CREX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2833000.00
CREX income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 2833000.00
CREX income_statement (annual, 2022-12-31) — Diluted Average Shares: 6664666.00
CREX income_statement (annual, 2022-12-31) — Diluted EPS: 0.28
CREX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1876000.00
CREX income_statement (annual, 2022-12-31) — EBIT: 4698000.00
CREX income_statement (annual, 2022-12-31) — EBITDA: 7531000.00
CREX cash_flow (annual, 2022-12-31) — End Cash Position: 1633000.00
CREX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 20933000.00
CREX cash_flow (annual, 2022-12-31) — Free Cash Flow: -4997000.00
CREX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -7557000.00
CREX income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 7557000.00
CREX income_statement (annual, 2022-12-31) — General And Administrative Expense: 11892000.00
CREX balance_sheet (annual, 2022-12-31) — Goodwill: 26453000.00
CREX balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 50205000.00
CREX balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 9247000.00
CREX balance_sheet (annual, 2022-12-31) — Gross PPE: 2242000.00
CREX income_statement (annual, 2022-12-31) — Gross Profit: 17739000.00
CREX cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 43000.00
CREX income_statement (annual, 2022-12-31) — Interest Expense: 2743000.00
CREX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2743000.00
CREX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1350000.00
CREX balance_sheet (annual, 2022-12-31) — Inventory: 2267000.00
CREX balance_sheet (annual, 2022-12-31) — Invested Capital: 43151000.00
CREX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -21475000.00
CREX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1814000.00
CREX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 11868000.00
CREX balance_sheet (annual, 2022-12-31) — Leases: 197000.00
CREX balance_sheet (annual, 2022-12-31) — Line Of Credit: 2000000.00
CREX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 873000.00
CREX balance_sheet (annual, 2022-12-31) — Long Term Debt: 13073000.00
CREX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 13946000.00
CREX cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 9868000.00
CREX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1044000.00
CREX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 199000.00
CREX cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -17186000.00
CREX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 1814000.00
CREX balance_sheet (annual, 2022-12-31) — Net Debt: 15939000.00
CREX income_statement (annual, 2022-12-31) — Net Income: 1876000.00
CREX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1876000.00
CREX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1876000.00
CREX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1876000.00
CREX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1876000.00
CREX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1876000.00
CREX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1876000.00
CREX income_statement (annual, 2022-12-31) — Net Interest Income: -2743000.00
CREX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 10824000.00
CREX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 8824000.00
CREX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2743000.00
CREX balance_sheet (annual, 2022-12-31) — Net PPE: 1785000.00
CREX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -149000.00
CREX cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 2000000.00
CREX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -24626000.00
CREX income_statement (annual, 2022-12-31) — Normalized EBITDA: 941000.00
CREX income_statement (annual, 2022-12-31) — Normalized Income: -4447764.00
CREX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -708000.00
CREX cash_flow (annual, 2022-12-31) — Operating Gains Losses: -6345000.00
CREX income_statement (annual, 2022-12-31) — Operating Income: -1888000.00
CREX income_statement (annual, 2022-12-31) — Operating Revenue: 43350000.00
CREX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 7265999.00
CREX balance_sheet (annual, 2022-12-31) — Other Current Assets: 1819000.00
CREX balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 2499000.00
CREX income_statement (annual, 2022-12-31) — Other Gand A: 11892000.00
CREX income_statement (annual, 2022-12-31) — Other Income Expense: 6586000.00
CREX balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 23752000.00
CREX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 431000.00
CREX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 43000.00
CREX balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 9994000.00
CREX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -4000.00
CREX income_statement (annual, 2022-12-31) — Other Operating Expenses: 592000.00
CREX balance_sheet (annual, 2022-12-31) — Other Properties: 1846000.00
CREX income_statement (annual, 2022-12-31) — Other Special Charges: 1449000.00
CREX balance_sheet (annual, 2022-12-31) — Payables: 3757000.00
CREX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 7585000.00
CREX cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 0.00
CREX income_statement (annual, 2022-12-31) — Pretax Income: 1955000.00
CREX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 8295000.00
CREX balance_sheet (annual, 2022-12-31) — Properties: 0.00
CREX cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 1673000.00
CREX cash_flow (annual, 2022-12-31) — Purchase Of Business: -17186000.00
CREX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -149000.00
CREX balance_sheet (annual, 2022-12-31) — Raw Materials: 1671000.00
CREX balance_sheet (annual, 2022-12-31) — Receivables: 8263000.00
CREX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 25611000.00
CREX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2833000.00
CREX cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1044000.00
CREX income_statement (annual, 2022-12-31) — Research And Development: 1251000.00
CREX income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: -482000.00
CREX balance_sheet (annual, 2022-12-31) — Retained Earnings: -50409000.00
CREX income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 3651000.00
CREX income_statement (annual, 2022-12-31) — Selling General And Administration: 15543000.00
CREX balance_sheet (annual, 2022-12-31) — Share Issued: 7265999.00
CREX cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 2000000.00
CREX cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
CREX income_statement (annual, 2022-12-31) — Special Income Charges: -967000.00
CREX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2116000.00
CREX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 25579000.00
CREX balance_sheet (annual, 2022-12-31) — Tangible Book Value: -24626000.00
CREX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 266236.00
CREX income_statement (annual, 2022-12-31) — Tax Provision: 79000.00
CREX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.04
CREX balance_sheet (annual, 2022-12-31) — Total Assets: 66015000.00
CREX balance_sheet (annual, 2022-12-31) — Total Capitalization: 38652000.00
CREX balance_sheet (annual, 2022-12-31) — Total Debt: 19156000.00
CREX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 25579000.00
CREX income_statement (annual, 2022-12-31) — Total Expenses: 45238000.00
CREX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 40436000.00
CREX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 52033000.00
CREX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 23940000.00
CREX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -2480000.00
CREX income_statement (annual, 2022-12-31) — Total Unusual Items: 6590000.00
CREX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 6590000.00
CREX balance_sheet (annual, 2022-12-31) — Work In Process: 596000.00
CREX balance_sheet (annual, 2022-12-31) — Working Capital: -2514000.00
CREX income_statement (annual, 2023-12-31) — +Operating Expense: 20837000.00
CREX income_statement (annual, 2023-12-31) — +Total Revenue: 45166000.00
CREX balance_sheet (annual, 2023-12-31) — Accounts Payable: 7876000.00
CREX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 12468000.00
CREX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -473000.00
CREX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 82073000.00
CREX balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -701000.00
CREX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 153000.00
CREX income_statement (annual, 2023-12-31) — Basic Average Shares: 8479000.00
CREX income_statement (annual, 2023-12-31) — Basic EPS: -0.35
CREX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1633000.00
CREX cash_flow (annual, 2023-12-31) — Capital Expenditure: -4027000.00
CREX cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -3721000.00
CREX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1041000.00
CREX balance_sheet (annual, 2023-12-31) — Capital Stock: 104000.00
CREX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2910000.00
CREX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 2910000.00
CREX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 137000.00
CREX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -4027000.00
CREX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 5167000.00
CREX cash_flow (annual, 2023-12-31) — Change In Account Payable: 4486000.00
CREX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -47000.00
CREX cash_flow (annual, 2023-12-31) — Change In Inventory: -409000.00
CREX cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 528000.00
CREX cash_flow (annual, 2023-12-31) — Change In Payable: 4486000.00
CREX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 4439000.00
CREX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 952000.00
CREX cash_flow (annual, 2023-12-31) — Change In Receivables: -4358000.00
CREX cash_flow (annual, 2023-12-31) — Change In Working Capital: 1152000.00
CREX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -4358000.00
CREX cash_flow (annual, 2023-12-31) — Changes In Cash: 1277000.00
CREX balance_sheet (annual, 2023-12-31) — Common Stock: 104000.00
CREX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 28831000.00
CREX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 5454000.00
CREX income_statement (annual, 2023-12-31) — Cost Of Revenue: 22983000.00
CREX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 3761000.00
CREX balance_sheet (annual, 2023-12-31) — Current Assets: 18610000.00
CREX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 505000.00
CREX balance_sheet (annual, 2023-12-31) — Current Debt: 3690000.00
CREX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4195000.00
CREX balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 4365000.00
CREX balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 4365000.00
CREX balance_sheet (annual, 2023-12-31) — Current Liabilities: 20197000.00
CREX cash_flow (annual, 2023-12-31) — Deferred Income Tax: 44000.00
CREX cash_flow (annual, 2023-12-31) — Deferred Tax: 44000.00
CREX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 3221000.00
CREX income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 3221000.00
CREX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 3221000.00
CREX income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 3221000.00
CREX income_statement (annual, 2023-12-31) — Diluted Average Shares: 8479000.00
CREX income_statement (annual, 2023-12-31) — Diluted EPS: -0.35
CREX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -2937000.00
CREX income_statement (annual, 2023-12-31) — EBIT: 138000.00
CREX income_statement (annual, 2023-12-31) — EBITDA: 3359000.00
CREX cash_flow (annual, 2023-12-31) — End Cash Position: 2910000.00
CREX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 137000.00
CREX cash_flow (annual, 2023-12-31) — Free Cash Flow: 1140000.00
CREX income_statement (annual, 2023-12-31) — General And Administrative Expense: 15590000.00
CREX balance_sheet (annual, 2023-12-31) — Goodwill: 26453000.00
CREX balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 50515000.00
CREX balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 13169000.00
CREX balance_sheet (annual, 2023-12-31) — Gross PPE: 2013000.00
CREX income_statement (annual, 2023-12-31) — Gross Profit: 22183000.00
CREX cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 78000.00
CREX income_statement (annual, 2023-12-31) — Interest Expense: 2992000.00
CREX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2992000.00
CREX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1685000.00
CREX balance_sheet (annual, 2023-12-31) — Inventory: 2567000.00
CREX balance_sheet (annual, 2023-12-31) — Invested Capital: 42350000.00
CREX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -4027000.00
CREX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 5454000.00
CREX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CREX balance_sheet (annual, 2023-12-31) — Leases: 298000.00
CREX balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
CREX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 536000.00
CREX balance_sheet (annual, 2023-12-31) — Long Term Debt: 9829000.00
CREX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 10365000.00
CREX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CREX cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -5317000.00
CREX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 205000.00
CREX cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CREX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 5454000.00
CREX balance_sheet (annual, 2023-12-31) — Net Debt: 10609000.00
CREX income_statement (annual, 2023-12-31) — Net Income: -2937000.00
CREX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -2937000.00
CREX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -2937000.00
CREX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -2937000.00
CREX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -2937000.00
CREX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -2937000.00
CREX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -2937000.00
CREX income_statement (annual, 2023-12-31) — Net Interest Income: -2992000.00
CREX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -5317000.00
CREX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -5317000.00
CREX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2992000.00
CREX balance_sheet (annual, 2023-12-31) — Net PPE: 1540000.00
CREX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -306000.00
CREX cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -2000000.00
CREX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -21684000.00
CREX income_statement (annual, 2023-12-31) — Normalized EBITDA: 4778000.00
CREX income_statement (annual, 2023-12-31) — Normalized Income: -1815990.00
CREX cash_flow (annual, 2023-12-31) — Operating Cash Flow: 5167000.00
CREX income_statement (annual, 2023-12-31) — Operating Income: 1346000.00
CREX income_statement (annual, 2023-12-31) — Operating Revenue: 45166000.00
CREX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 10409027.00
CREX balance_sheet (annual, 2023-12-31) — Other Current Assets: 665000.00
CREX balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 3690000.00
CREX income_statement (annual, 2023-12-31) — Other Gand A: 15590000.00
CREX income_statement (annual, 2023-12-31) — Other Income Expense: -1208000.00
CREX balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 24062000.00
CREX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2862000.00
CREX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 112000.00
CREX balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 11384000.00
CREX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 211000.00
CREX balance_sheet (annual, 2023-12-31) — Other Properties: 1510000.00
CREX balance_sheet (annual, 2023-12-31) — Payables: 7876000.00
CREX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 11637000.00
CREX income_statement (annual, 2023-12-31) — Pretax Income: -2854000.00
CREX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
CREX balance_sheet (annual, 2023-12-31) — Properties: 0.00
CREX cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 109000.00
CREX cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CREX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -306000.00
CREX balance_sheet (annual, 2023-12-31) — Raw Materials: 2063000.00
CREX balance_sheet (annual, 2023-12-31) — Receivables: 12468000.00
CREX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 22983000.00
CREX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 3221000.00
CREX cash_flow (annual, 2023-12-31) — Repayment Of Debt: -5317000.00
CREX income_statement (annual, 2023-12-31) — Research And Development: 1574000.00
CREX income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 1419000.00
CREX balance_sheet (annual, 2023-12-31) — Retained Earnings: -53346000.00
CREX income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 5247000.00
CREX income_statement (annual, 2023-12-31) — Selling General And Administration: 20837000.00
CREX balance_sheet (annual, 2023-12-31) — Share Issued: 10409027.00
CREX cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00